List of Contents

Closed System Transfer Devices Market Size, Share, and Trends 2024 to 2034

The global closed system transfer device market size was USD 1.30 billion in 2023, estimated at USD 1.43 billion in 2024 and is anticipated to reach around USD 3.66 billion by 2034, expanding at a CAGR of 9.84% from 2024 to 2034.

  • Last Updated : August 2024
  • Report Code : 1180
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Regenerative Medicine Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Regenerative Medicine Market

5.1. Covid-19: Regenerative Medicine Industry Impact
5.2. Regenerative Medicine Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Regenerative Medicine Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Regenerative Medicine Market Players to deal with Covid-19 Pandemic Scenario

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Increasing prevalence of cancer
6.1.1.2. Growing need for regulatory compliance for safe handling of harmful drugs
6.1.2. Market Restraints
6.1.2.1. High cost systems
6.1.3. Market Opportunities
6.1.3.1. Rising adoption of closed system transfer devices for transferring hazardous drugs
6.1.3.2. Increasing use of CSTDs in emerging markets

Chapter 7. Global Regenerative Medicine Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Regenerative Medicine Market Revenue by Market Players
7.1.1.2. Regenerative Medicine Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Regenerative Medicine Market, By Product

8.1. Regenerative Medicine Market, by Product, 2024-2034
8.1.1. Needleless Systems
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Membrane-to-Membrane Systems
8.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Regenerative Medicine Market, By Closing Mechanism

9.1. Regenerative Medicine Market, by Application, 2024-2034
9.1.1. Color-To-Color Alignment Systems
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Push-To-Turn Systems
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Click-To-Lock Systems
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Luer-Lock Systems
9.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Regenerative Medicine Market, By Component

10.1. Regenerative Medicine Market, by Application, 2024-2034
10.1.1. Syringe Safety Devices
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Vial Access Devices
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Accessories
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Bag/Line Access Devices
10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Regenerative Medicine Market, By End User

11.1. Regenerative Medicine Market, by Application, 2024-2034
11.1.1. Clinics & Oncology Centers
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Hospitals
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Regenerative Medicine Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Type (2021-2034)
12.1.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.1.3. Market Revenue Forecast by Component (2021-2034)
12.1.4. Market Revenue Forecast by End User (2021-2034)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2034)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2034)
12.2. Europe
12.2.1. Market Revenue Forecast by Type (2021-2034)
12.2.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.2.3. Market Revenue Forecast by Component (2021-2034)
12.2.4. Market Revenue Forecast by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2034)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2034)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Type (2021-2034)
12.3.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.3.3. Market Revenue Forecast by Component (2021-2034)
12.3.4. Market Revenue Forecast by End User (2021-2034)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2034)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2034)
12.4. LATAM
12.4.1. Market Revenue Forecast by Type (2021-2034)
12.4.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.4.3. Market Revenue Forecast by Component (2021-2034)
12.4.4. Market Revenue Forecast by End User (2021-2034)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2034)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2034)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Type (2021-2034)
12.5.2. Market Revenue Forecast by Closing Mechanism (2021-2034)
12.5.3. Market Revenue Forecast by Component (2021-2034)
12.5.4. Market Revenue Forecast by End User (2021-2034)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2034)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2034)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2034)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2034)

Chapter 13. Company Profiles

13.1. Baxter International Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. ProductPortfolio Analysis
13.1.2.1. ProductDetails, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Becton, Dickinson, and Company
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. CodanMedizinischeGeräte GmbH & Co Kg
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. ICU Medical, Inc.
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Yukon Medical
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. B. Braun Melsungen
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Equashield
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. Teva Pharmaceutical Industries Ltd.
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Victus, Inc.
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Corvida Medical
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global closed system transfer device market size stood at USD 3.66 billion in 2023 and is predicted to reach USD 3.66 billion by the end of 2034.

The global closed system transfer device market is growing at a CAGR of 9.84% during the forecast period 2024 to 2034.

Factors such as growing prevalence of cancer and rising need for monitoring compliance for harmless handling of damaging drugs are driving the growth of closed system transfer device market.

In 2022, North America dominated the global market with a market share of more than 42%.

Asia Pacific is anticipated to grow at the maximum CAGR of around 18% in the forecast period due to high incidence of cancer.

The major companies operating in the worldwide closed system transfer device are Baxter International Inc., Becton, Dickinson, and Company, CodanMedizinischeGeräte GmbH & Co Kg, ICU Medical, Inc., Yukon Medical, B. Braun Melsungen, Equashield, Teva Pharmaceutical Industries Ltd., Victus, Inc., and Corvida Medical among others.

Push-To-Turn systems projected to rule the closing mechanism segment of closed system transfer device market revenue.

Hospitals Projected to Dominate the End-User Segment of Closed System Transfer Device Market Revenue.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us